Anika Therapeutics Inc. (ANIK) Jumps 5.34% on January 26

Equities Staff |

Anika Therapeutics Inc. (ANIK) was among the biggest gainers on the Russell 2000 for Tuesday January 26 as the stock popped 5.34% to $38.26, representing a gain of $1.94 per share. Some 128,139 shares traded hands on 1,147 trades, compared with an average daily volume of 143,090 shares out of a total float of 14.64 million. The stock opened at $36.61 and traded with an intraday range of $38.57 to $36.06.

After today's gains, Anika Therapeutics Inc. reached a market cap of $560.04 million. Anika Therapeutics Inc. has had a trading range between $45.35 and $30.93 over the last year, and it had a 50-day SMA of $39.43 and a 200-day SMA of $36.21.

The stock has a P/E Ratio of 19.8.

Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The Company through its subsidiary has over 20 products currently commercialized, mainly in Europe.

Anika Therapeutics Inc. is based out of Bedford, MA and has some 105 employees. Its CEO is Charles H. Sherwood.

For a complete fundamental analysis analysis of Anika Therapeutics Inc., check out’s Stock Valuation Analysis report for ANIK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…